Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,179 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $424.61 | 14 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $215.82 | 4 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $126.23 | 1 | $0 (2023) |
| Amgen Inc. | $105.91 | 1 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $97.50 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $96.46 | 1 | $0 (2024) |
| UCB, Inc. | $39.65 | 2 | $0 (2024) |
| MDD US Operations, LLC | $35.02 | 2 | $0 (2023) |
| Shield Therapeutics Inc | $19.66 | 1 | $0 (2023) |
| Lundbeck LLC | $18.57 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $478.50 | 12 | Otsuka America Pharmaceutical, Inc. ($233.30) |
| 2023 | $603.43 | 15 | ACADIA Pharmaceuticals Inc ($215.82) |
| 2022 | $97.50 | 1 | IDORSIA PHARMACEUTICALS US INC ($97.50) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: PSYCHIATRY | ||||||
| 09/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: PSYCHIATRY | ||||||
| 08/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: PSYCHIATRY | ||||||
| 07/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: PSYCHIATRY | ||||||
| 05/23/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $105.91 | General |
| Category: Bone Health | ||||||
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $96.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/19/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Neurology | ||||||
| 04/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.57 | General |
| Category: PSYCHIATRY | ||||||
| 03/08/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROLOGY | ||||||
| 02/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/08/2023 | MDD US Operations, LLC | GOCOVRI (Drug) | Food and Beverage | Cash or cash equivalent | $21.44 | General |
| Category: NEUROLOGY | ||||||
| 11/10/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $3.49 | General |
| Category: NEUROLOGY | ||||||
| 11/06/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Hematology | ||||||
| 11/04/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Neurology | ||||||
| 10/28/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: NEUROLOGY | ||||||
| 10/14/2023 | MDD US Operations, LLC | APOKYN (Drug) | Food and Beverage | Cash or cash equivalent | $13.58 | General |
| Category: NEUROLOGY | ||||||
| 10/05/2023 | Neurocrine Biosciences, Inc. | Ongentys (Drug) | Food and Beverage | In-kind items and services | $126.23 | General |
| Category: Neuropsychiatry | ||||||
| 09/30/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: NEUROLOGY | ||||||
| 09/14/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $119.28 | General |
| Category: PSYCHIATRY | ||||||
| 08/25/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: NEUROLOGY | ||||||
| 07/07/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: NEUROLOGY | ||||||
| 05/25/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $90.68 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/25/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $90.68 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 569 | 1,531 | $261,210 | $103,730 |
| 2022 | 9 | 629 | 1,803 | $319,968 | $100,054 |
| 2021 | 8 | 487 | 1,473 | $229,987 | $76,289 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 155 | 768 | $127,968 | $51,803 | 40.5% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 48 | 166 | $34,750 | $13,086 | 37.7% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 100 | 118 | $23,598 | $11,807 | 50.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 51 | 145 | $24,104 | $9,737 | 40.4% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 51 | 130 | $20,350 | $5,898 | 29.0% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 35 | 35 | $6,294 | $2,840 | 45.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 38 | 62 | $7,720 | $2,392 | 31.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 25 | 37 | $4,498 | $1,580 | 35.1% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2023 | 29 | 30 | $4,300 | $1,564 | 36.4% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 11 | 12 | $3,537 | $1,465 | 41.4% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 11 | 12 | $2,349 | $1,204 | 51.3% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 15 | 16 | $1,742 | $354.18 | 20.3% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 192 | 1,026 | $186,732 | $59,168 | 31.7% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 61 | 173 | $32,870 | $10,162 | 30.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 53 | 122 | $22,204 | $6,654 | 30.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 59 | 133 | $18,354 | $5,416 | 29.5% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 47 | 58 | $15,660 | $5,096 | 32.5% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 67 | 97 | $13,386 | $4,202 | 31.4% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2022 | 61 | 62 | $9,114 | $2,808 | 30.8% |
| 99334 | Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | Office | 2022 | 42 | 71 | $8,662 | $2,649 | 30.6% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 21 | 32 | $8,576 | $2,565 | 29.9% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2022 | 15 | 15 | $3,150 | $1,021 | 32.4% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 11 | 14 | $1,260 | $314.80 | 25.0% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 99 | 479 | $87,178 | $28,986 | 33.2% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 112 | 487 | $67,206 | $22,387 | 33.3% |
About Amara Sluder
Amara Sluder is a Family healthcare provider based in Lees Summit, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2020. The National Provider Identifier (NPI) number assigned to this provider is 1255958369.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amara Sluder has received a total of $1,179 in payments from pharmaceutical and medical device companies, with $478.50 received in 2024. These payments were reported across 28 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,179).
As a Medicare-enrolled provider, Sluder has provided services to 1,685 Medicare beneficiaries, totaling 4,807 services with total Medicare billing of $280,073. Data is available for 3 years (2021–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Lees Summit, MO
- Active Since 07/06/2020
- Last Updated 07/06/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1255958369
Products in Payments
- REXULTI (Drug) $354.15
- NUPLAZID (Drug) $215.82
- Ongentys (Drug) $126.23
- EVENITY (Biological) $105.91
- QUVIVIQ (Drug) $97.50
- LOKELMA (Drug) $96.46
- NUEDEXTA (Drug) $89.03
- Briviact (Drug) $24.26
- GOCOVRI (Drug) $21.44
- ACCRUFER (Drug) $19.66
- Nayzilam (Drug) $15.39
- APOKYN (Drug) $13.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Lees Summit
Tamera Wolf, Fnp, FNP
Family — Payments: $144,477
Narin Tipton, Cnp, CNP
Family — Payments: $15,595
Crystal Davison, Aprn, APRN
Family — Payments: $10,819
Christine Hunt
Family — Payments: $9,165
Stephanie Justin, Cnp, CNP
Family — Payments: $7,270
Rachel Walter, Np-C, NP-C
Family — Payments: $7,257